Condition: Acute Myeloid Leukemia · Sponsor: PedAL BCU, LLC
A study to evaluate if the randomized addition of venetoclax to a chemotherapy backbone (fludarabine/cytarabine/gemtuzumab ozogamicin \[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse who are unable to receive additional anthracyclines, or in 2nd relapse.
This description comes directly from the study's public registry record.
Gwen Nichols, MD · 914-821-8217 · gwen.nichols@lls.org
Michel Zwaan · +31 88 972 5206 · c.m.zwaan@prinsesmaximacentrum.nl
Always discuss trial participation with your own doctor first.
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Recruiting |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | Recruiting |
| MemorialCare Miller Children's and Women's Hospital Long Beach | Long Beach, California, United States | Recruiting |
| Children's Hospital of Orange County Main Campus - Orange | Orange, California, United States | Recruiting |
| Benioff Children's Hospital - Mission Bay | San Francisco, California, United States | Recruiting |
| Children's Hospital Colorado | Aurora, Colorado, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| Nemours Alfred I. Dupont Hospital for Children | Wilmington, Delaware, United States | Recruiting |
| Children's National - Main Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| Golisano Children's Hospital of Southwest Florida | Fort Myers, Florida, United States | Recruiting |
| University of Florida Health Shands Children's Hospital | Gainesville, Florida, United States | Recruiting |
| Nemours Children's Specialty Care Jacksonville | Jacksonville, Florida, United States | Recruiting |
+ 78 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05183035